Arthur Kavanaugh, MD, University of California, San Diego, La Jolla, CA, United States; Gerald Krueger, MD, University of Utah Health Sciences Center, Salt Lake City, UT, United States; Songkai Yan, PhD, Centocor, Inc., Malvern, PA, United States; Christian Antoni, MD, Friedrich-Alexander University, Erlangen, GermanyLe texte complet de cet article est disponible en PDF.
Dr. Kavanaugh has consulted and particpated in clinical research sponsored by Centocor, Amgen, and Abbott. Dr. Antoni is an investigator and consultant for infliximab at Centocor. Dr. Krueger is a consultant to Biogen, Genentech, and Centocor; on the sponsored speakers list for Amgen, Biogen, Genentech, and Centocor; neither Dr. Krueger nor his family own stock in these companies. Dr. Krueger has also participated in clinical trials for each of these companies.
These studies were funded by a research grant from Centocor (IMPACT) or have been done by Centocor (IMPACT 2).